Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Romano, L; Venturi, G; Vivarelli, A; Galli, L; Zazzi, M
   Detection of a drug-resistant human immunodeficiency virus variant in a newly infected heterosexual couple
   CLINICAL INFECTIOUS DISEASES
   
   L. Romano et al., "Detection of a drug-resistant human immunodeficiency virus variant in a newly infected heterosexual couple", CLIN INF D, 34(1), 2002, pp. 116-117
2. Carrieri, P; Cailleton, V; Le Moing, V; Spire, B; Dellamonica, P; Bouvet, E; Raffi, F; Journot, V; Moatti, JP
   The dynamic of adherence to highly active antiretroviral therapy: Results from the French National APROCO cohort
   JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
   
   P. Carrieri et al., "The dynamic of adherence to highly active antiretroviral therapy: Results from the French National APROCO cohort", J ACQ IMM D, 28(3), 2001, pp. 232-239
3. Monforte, AD; Bugarini, R; Pezzotti, P; De Luca, A; Antinori, A; Mussini, C; Vigevani, GM; Tirelli, U; Bruno, R; Gritti, F; Piazza, M; Chigiotti, S; Chirianni, A; De Stefano, C; Pizzigallo, E; Perrella, O; Moroni, M
   Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART
   JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
   
   A.D. Monforte et al., "Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART", J ACQ IMM D, 28(2), 2001, pp. 114-123
4. Shulman, NS; Machekano, RA; Shafer, RW; Winters, MA; Zolopa, AR; Liou, SH; Hughes, M; Katzenstein, DA
   Genotypic correlates of a virologic response to stavudine after zidovudinemonotherapy
   JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
   
   N.S. Shulman et al., "Genotypic correlates of a virologic response to stavudine after zidovudinemonotherapy", J ACQ IMM D, 27(4), 2001, pp. 377-380
5. Bogner, JR; Vielhauer, V; Beckmann, RA; Michl, G; Wille, L; Salzberger, B; Goebel, FD
   Stavudine versus zidovudine and the development of lipodystrophy
   JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
   
   J.R. Bogner et al., "Stavudine versus zidovudine and the development of lipodystrophy", J ACQ IMM D, 27(3), 2001, pp. 237-244
6. Rousseau, MN; Vergne, L; Montes, B; Peeters, M; Reynes, J; Delaporte, E; Segondy, M
   Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-Infected patients with failure of highly active antiretroviral therapy
   JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
   
   M.N. Rousseau et al., "Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-Infected patients with failure of highly active antiretroviral therapy", J ACQ IMM D, 26(1), 2001, pp. 36-43
7. Becker, SL; Raffanti, SR; Hansen, NI; Fusco, JS; Fusco, GP; Slatko, GH; Igboko, EF; Graham, NMH
   Zidovudine and stavudine sequencing in HIV treatment planning: Findings from the CHORUS HIV cohort
   JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
   
   S.L. Becker et al., "Zidovudine and stavudine sequencing in HIV treatment planning: Findings from the CHORUS HIV cohort", J ACQ IMM D, 26(1), 2001, pp. 72-81
8. Plettenberg, A; Albrecht, D; Lorenzen, T; Paech, V; Petersen, H; Fenner, T; Meyer, T; Arndt, R; Hertogs, K; Pauwels, R; Weitzel, T; Stoehr, A
   Resistance analyses in HIV infected patients with a history of multiple antiretroviral treatment regimens
   SEXUALLY TRANSMITTED INFECTIONS
   
   A. Plettenberg et al., "Resistance analyses in HIV infected patients with a history of multiple antiretroviral treatment regimens", SEX TRANS I, 77(6), 2001, pp. 449-452
9. Miller, V; Larder, BA
   Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure
   ANTIVIRAL THERAPY
   
   V. Miller e B.A. Larder, "Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure", ANTIVIR TH, 6, 2001, pp. 25-44
10. Wainberg, MA; White, AJ
    Current insights into reverse transcriptase inhibitor-associated resistance
    ANTIVIRAL THERAPY
    
    M.A. Wainberg e A.J. White, "Current insights into reverse transcriptase inhibitor-associated resistance", ANTIVIR TH, 6, 2001, pp. 11-19
11. Ross, L; Henry, K; Paar, D; Salvato, P; Shaefer, M; Fisher, R; Liao, QM; St Clair, M
    Thymidine-analog and multi-nucleoside resistance mutations are observed inboth zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens
    JOURNAL OF HUMAN VIROLOGY
    
    L. Ross et al., "Thymidine-analog and multi-nucleoside resistance mutations are observed inboth zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens", J HUMAN VIR, 4(4), 2001, pp. 217-222
12. Manfredi, R; Calza, L; Chiodo, F
    Gynecomastia associated with highly active antiretroviral therapy
    ANNALS OF PHARMACOTHERAPY
    
    R. Manfredi et al., "Gynecomastia associated with highly active antiretroviral therapy", ANN PHARMAC, 35(4), 2001, pp. 438-439
13. Duong, M; Piroth, L; Peytavin, G; Forte, F; Kohli, E; Grappin, M; Buisson, M; Chavanet, P; Portier, H
    Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response
    CLINICAL INFECTIOUS DISEASES
    
    M. Duong et al., "Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response", CLIN INF D, 33(3), 2001, pp. 386-392
14. Coghlan, ME; Sommadossi, JP; Jhala, NC; Many, WJ; Saag, MS; Johnson, VA
    Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: A report of 12 cases
    CLINICAL INFECTIOUS DISEASES
    
    M.E. Coghlan et al., "Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: A report of 12 cases", CLIN INF D, 33(11), 2001, pp. 1914-1921
15. Ballatore, C; McGuigan, C; De Clercq, E; Balzarini, J
    Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    C. Ballatore et al., "Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPA", BIOORG MED, 11(8), 2001, pp. 1053-1056
16. Arici, C; Tebaldi, A; Quinzan, GP; Maggiolo, F; Ripamonti, D; Suter, F
    Severe lactic acidosis and thiamine administration in an HIV-infected patient on HAART
    INTERNATIONAL JOURNAL OF STD & AIDS
    
    C. Arici et al., "Severe lactic acidosis and thiamine administration in an HIV-infected patient on HAART", INT J STD A, 12(6), 2001, pp. 407-409
17. Zhang, LP; Price, R; Aweeka, F; Bellibas, SE; Sheiner, LB
    Making the most of sparse clinical data by using a predictive-model-based analysis, illustrated with a stavudine pharmacokinetic study
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    
    L.P. Zhang et al., "Making the most of sparse clinical data by using a predictive-model-based analysis, illustrated with a stavudine pharmacokinetic study", EUR J PH SC, 12(4), 2001, pp. 377-385
18. Kline, MW; Brundage, RC; Fletcher, CV; Schwarzwald, H; Calles, NR; Buss, NE; Snell, P; Delora, P; Eason, M; Jorga, K; Craig, C; Duff, F
    Combination therapy with saquinavir soft gelatin capsules in children withhuman immunodeficiency virus infection
    PEDIATRIC INFECTIOUS DISEASE JOURNAL
    
    M.W. Kline et al., "Combination therapy with saquinavir soft gelatin capsules in children withhuman immunodeficiency virus infection", PEDIAT INF, 20(7), 2001, pp. 666-671
19. Ross, L; Liao, QM; Gao, HT; Pham, S; Tolson, J; Hertogs, K; Larder, B; Saag, MS
    Impact of HIV type 1 drug resistance mutations and phenotypic resistance profile on virologic response to salvage therapy
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    L. Ross et al., "Impact of HIV type 1 drug resistance mutations and phenotypic resistance profile on virologic response to salvage therapy", AIDS RES H, 17(15), 2001, pp. 1379-1385
20. Tatsunami, S; Ito, A; Kawata, K; Kuwabara, R; Yamada, K
    Determination of pharmacokinetic parameters of stavudine in Japanese patients infected with HIV-1, using a Gaussian-like input rate function
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    
    S. Tatsunami et al., "Determination of pharmacokinetic parameters of stavudine in Japanese patients infected with HIV-1, using a Gaussian-like input rate function", EUR J DRUG, 26(1-2), 2001, pp. 137-140
21. Soriano, V
    Sequencing antiretroviral drugs
    AIDS
    
    V. Soriano, "Sequencing antiretroviral drugs", AIDS, 15(5), 2001, pp. 547-551
22. Moore, RD; Keruly, JC; Chaisson, RE
    Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs
    AIDS
    
    R.D. Moore et al., "Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs", AIDS, 15(5), 2001, pp. 617-620
23. Bartlett, JA; DeMasi, R; Quinn, J; Moxham, C; Rousseau, F
    Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults
    AIDS
    
    J.A. Bartlett et al., "Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults", AIDS, 15(11), 2001, pp. 1369-1377
24. Havlir, DV; Gilbert, PB; Bennett, K; Collier, AC; Hirsch, MS; Tebas, P; Adams, EM; Wheat, LJ; Goodwin, D; Schnittman, S; Holohan, MK; Richman, DD
    Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression
    AIDS
    
    D.V. Havlir et al., "Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression", AIDS, 15(11), 2001, pp. 1379-1388
25. Sarmati, L; Nicastri, E; Parisi, SG; D'Ettorre, G; Narciso, P; Mancino, G; Gallo, I; Abbadessa, V; Dalle, NER; Traina, C; Vullo, V; Andreoni, M
    Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations
    JOURNAL OF MEDICAL VIROLOGY
    
    L. Sarmati et al., "Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations", J MED VIROL, 65(4), 2001, pp. 631-636
26. Attaran, A; Gillespie-White, L
    Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa?
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    
    A. Attaran e L. Gillespie-White, "Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa?", J AM MED A, 286(15), 2001, pp. 1886-1892
27. Chen, CL; Venkatachalam, TK; Zhu, ZH; Uckun, FM
    In vivo pharmacokinetics and metabolism of anti-human immunodeficiency virus agent D4T-5 '-[P-bromophenyl methoxyalaninyl phosphate] (sampidine) in mice
    DRUG METABOLISM AND DISPOSITION
    
    C.L. Chen et al., "In vivo pharmacokinetics and metabolism of anti-human immunodeficiency virus agent D4T-5 '-[P-bromophenyl methoxyalaninyl phosphate] (sampidine) in mice", DRUG META D, 29(7), 2001, pp. 1035-1041
28. Saez-Llorens, X; Nelson, RP; Emmanuel, P; Wiznia, A; Mitchell, C; Church, JA; Sleasman, J; Van Dyke, R; Richardson, CG; Cutrell, A; Spreen, W; Hetherington, S
    A randomized, double-blind study of triple nucleoside therapy of abacavir,lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children
    PEDIATRICS
    
    X. Saez-Llorens et al., "A randomized, double-blind study of triple nucleoside therapy of abacavir,lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children", PEDIATRICS, 107(1), 2001, pp. NIL_25-NIL_35
29. Garcia-Lerma, JG; Nidtha, S; Blumoff, K; Weinstock, H; Heneine, W
    Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    J.G. Garcia-Lerma et al., "Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons", P NAS US, 98(24), 2001, pp. 13907-13912
30. Kazatchkine, MD; Van, PN; Costagliola, D; Mohammed, AS; Ledeine, JM; Troccaz, M; Belec, L
    Didanosine dosed once daily is equivalent to twice daily dosing for patients on double or triple combination antiretroviral therapy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    M.D. Kazatchkine et al., "Didanosine dosed once daily is equivalent to twice daily dosing for patients on double or triple combination antiretroviral therapy", J ACQ IMM D, 24(5), 2000, pp. 418-424
31. Rainey, PM; Friedland, G; McCance-Katz, EF; Andrews, L; Mitchell, SM; Charles, C; Jatlow, P
    Interaction of methadone with didanosine and stavudine
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    P.M. Rainey et al., "Interaction of methadone with didanosine and stavudine", J ACQ IMM D, 24(3), 2000, pp. 241-248
32. Sarasa, M; Riba, N; Zamora, L; Carne, X
    Determination of stavudine in human plasma and urine by high-performance liquid chromatography using a reduced sample volume
    JOURNAL OF CHROMATOGRAPHY B
    
    M. Sarasa et al., "Determination of stavudine in human plasma and urine by high-performance liquid chromatography using a reduced sample volume", J CHROMAT B, 746(2), 2000, pp. 183-189
33. Pillay, D; Taylor, S; Richman, DD
    Incidence and impact of resistance against approved antiretroviral drugs
    REVIEWS IN MEDICAL VIROLOGY
    
    D. Pillay et al., "Incidence and impact of resistance against approved antiretroviral drugs", REV MED VIR, 10(4), 2000, pp. 231-253
34. McGuigan, C; Bidois, L; Hiouni, A; Ballatore, C; De Clercq, E; Balzarini, J
    Phosphoramidate derivatives of stavudine as inhibitors of HIV: unnatural amino acids may substitute for alanine
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    
    C. McGuigan et al., "Phosphoramidate derivatives of stavudine as inhibitors of HIV: unnatural amino acids may substitute for alanine", ANTIVIR CHE, 11(2), 2000, pp. 111-116
35. Gandhi, RB; Bogardus, JB; Bugay, DE; Perrone, RK; Kaplan, MA
    Pharmaceutical relationships of three solid state forms of stavudine
    INTERNATIONAL JOURNAL OF PHARMACEUTICS
    
    R.B. Gandhi et al., "Pharmaceutical relationships of three solid state forms of stavudine", INT J PHARM, 201(2), 2000, pp. 221-237
36. Mouroux, M; Izopet, J; Descamps, D; Delaugerre, C; Yvon-Groussin, A; Angleraud, F; Coutellier, A; Bonmarchand, M; Valantin, MA; Matheron, S; Agut, H; Katlama, C; Brun-Vezinet, F; Calvez, V
    Conditions of selection of 'thymidine analogue mutations' (TAMs) in naive patients receiving different antiretroviral combinations including d4T.
    PATHOLOGIE BIOLOGIE
    
    M. Mouroux et al., "Conditions of selection of 'thymidine analogue mutations' (TAMs) in naive patients receiving different antiretroviral combinations including d4T.", PATH BIOL, 48(5), 2000, pp. 508-512
37. Bleeker-Rovers, CP; Kadir, SW; van Leusen, R; Richter, C
    Hepatic steatosis and lactic acidosis caused by stavudine in an HIV-infected patient
    NETHERLANDS JOURNAL OF MEDICINE
    
    C.P. Bleeker-Rovers et al., "Hepatic steatosis and lactic acidosis caused by stavudine in an HIV-infected patient", NETH J MED, 57(5), 2000, pp. 190-193
38. Carr, A; Chuah, J; Hudson, J; French, M; Hoy, J; Law, M; Sayer, D; Emery, S; Cooper, DA
    A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study
    AIDS
    
    A. Carr et al., "A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study", AIDS, 14(9), 2000, pp. 1171-1180
39. Gisolf, EH; Jurriaans, S; Pelgrom, J; van Wanzeele, F; van der Ende, ME; Brinkman, K; Borst, MJ; de Wolf, F; Japour, AJ; Danner, SA
    The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine
    AIDS
    
    E.H. Gisolf et al., "The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine", AIDS, 14(4), 2000, pp. 405-413
40. Coakley, EP; Gillis, JM; Hammer, SM
    Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine
    AIDS
    
    E.P. Coakley et al., "Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine", AIDS, 14(2), 2000, pp. F9-F15
41. Roca, B; Gomez, CJ; Arnedo, A
    A randomized, comparative study of lamivudine plus stavudine, with indinavir or nelfinavir, in treatment-experienced HIV-infected patients
    AIDS
    
    B. Roca et al., "A randomized, comparative study of lamivudine plus stavudine, with indinavir or nelfinavir, in treatment-experienced HIV-infected patients", AIDS, 14(2), 2000, pp. 157-161
42. Pollard, RB
    Didanosine once daily: potential for expanded use
    AIDS
    
    R.B. Pollard, "Didanosine once daily: potential for expanded use", AIDS, 14(16), 2000, pp. 2421-2428
43. Fletcher, CV; Kawle, SP; Kakuda, TN; Anderson, PL; Weller, D; Bushman, LR; Brundage, RC; Remmel, RP
    Zidovudine triphosphate and lamivudine triphosphate concentration-responserelationships in HIV-infected persons
    AIDS
    
    C.V. Fletcher et al., "Zidovudine triphosphate and lamivudine triphosphate concentration-responserelationships in HIV-infected persons", AIDS, 14(14), 2000, pp. 2137-2144
44. Rutschmann, OT; Vernazza, PL; Bucher, HC; Opravil, M; Ledergerber, B; Telenti, A; Malinverni, R; Bernasconi, E; Fagard, C; Leduc, D; Perrin, L; Hirschel, B
    Long-term hydroxyurea in combination with didanosine and stavudine for thetreatment of HIV-1 infection
    AIDS
    
    O.T. Rutschmann et al., "Long-term hydroxyurea in combination with didanosine and stavudine for thetreatment of HIV-1 infection", AIDS, 14(14), 2000, pp. 2145-2151
45. Taylor, S; van Heeswijk, RPG; Hoetelmans, RMW; Workman, J; Drake, SM; White, DJ; Pillay, D
    Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men
    AIDS
    
    S. Taylor et al., "Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men", AIDS, 14(13), 2000, pp. 1979-1984
46. Gisolf, EH; Enting, RH; Jurriaans, S; de Wolf, F; van der Ende, ME; Hoetelmans, RMW; Portegies, P; Danner, SA
    Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine
    AIDS
    
    E.H. Gisolf et al., "Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine", AIDS, 14(11), 2000, pp. 1583-1589
47. Squires, KE; Gulick, R; Tebas, P; Santana, J; Mulanovich, V; Clark, R; Yangco, B; Marlowe, SI; Wright, D; Cohen, C; Cooley, T; Mauney, J; Uffelman, K; Schoellkopf, N; Grosso, R; Stevens, M
    A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I)
    AIDS
    
    K.E. Squires et al., "A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I)", AIDS, 14(11), 2000, pp. 1591-1600
48. Eron, JJ; Murphy, RL; Peterson, D; Pottage, J; Parenti, DM; Jemsek, J; Swindells, S; Sepulveda, G; Bellos, N; Rashbaum, BC; Esinhart, J; Schoellkopf, N; Grosso, R; Stevens, M
    A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: Selection of thymidine analog regimen therapy (START II)
    AIDS
    
    J.J. Eron et al., "A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: Selection of thymidine analog regimen therapy (START II)", AIDS, 14(11), 2000, pp. 1601-1610
49. Ruxrungtham, K; Kroon, EDMB; Ungsedhapand, C; Teeratakulpisarn, S; Ubolyam, S; Buranapraditkun, S; van Leeuwen, R; Weverling, GJ; Kunanusont, C; Lange, JMA; Cooper, DA; Phanuphak, P
    A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients
    AIDS
    
    K. Ruxrungtham et al., "A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients", AIDS, 14(10), 2000, pp. 1375-1382
50. Shaer, AJ; Rastegar, A
    Lactic acidosis in the setting of antiretroviral therapy for the acquired immunodeficiency syndrome - A case report and review of the literature
    AMERICAN JOURNAL OF NEPHROLOGY
    
    A.J. Shaer e A. Rastegar, "Lactic acidosis in the setting of antiretroviral therapy for the acquired immunodeficiency syndrome - A case report and review of the literature", AM J NEPHR, 20(4), 2000, pp. 332-338
51. Genne, D; Sudre, P; Anwar, D; Goehring, C; Saaidia, A; Hirschel, B
    Causes of macrocytosis in HIV-infected patients not treated with zidovudine
    JOURNAL OF INFECTION
    
    D. Genne et al., "Causes of macrocytosis in HIV-infected patients not treated with zidovudine", J INFECTION, 40(2), 2000, pp. 160-163
52. Meyer, PR; Matsuura, SE; Schinazi, RF; So, AG; Scott, WA
    Differential removal of thymidine nucleotide analogues from blocked DNA chains by human immunodeficiency virus reverse transcriptase in the presence of physiological concentrations of 2 '-deoxynucleoside triphosphates
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    P.R. Meyer et al., "Differential removal of thymidine nucleotide analogues from blocked DNA chains by human immunodeficiency virus reverse transcriptase in the presence of physiological concentrations of 2 '-deoxynucleoside triphosphates", ANTIM AG CH, 44(12), 2000, pp. 3465-3472
53. Patterson, TA; Binienda, ZK; Newport, GD; Lipe, GW; Gillam, MP; Slikker, W; Sandberg, JK
    Transplacental pharmacokinetics and fetal distribution of 2 ',3 '-didehydro-3 '-deoxythymidine (d4T) and its metabolites in late-term rhesus macaques
    TERATOLOGY
    
    T.A. Patterson et al., "Transplacental pharmacokinetics and fetal distribution of 2 ',3 '-didehydro-3 '-deoxythymidine (d4T) and its metabolites in late-term rhesus macaques", TERATOLOGY, 62(2), 2000, pp. 93-99
54. Lasso, M; Perez, J; Noriega, LM; Northland, R
    Fatal lactic acidosis in a patient with acquired immunodeficiency syndrometreated with highly active antiretroviral therapy. Report one case
    REVISTA MEDICA DE CHILE
    
    M. Lasso et al., "Fatal lactic acidosis in a patient with acquired immunodeficiency syndrometreated with highly active antiretroviral therapy. Report one case", REV MED CHI, 128(10), 2000, pp. 1139-1143
55. Palumbo, PE
    Antiretroviral therapy of HIV infection in children
    PEDIATRIC CLINICS OF NORTH AMERICA
    
    P.E. Palumbo, "Antiretroviral therapy of HIV infection in children", PED CLIN NA, 47(1), 2000, pp. 155
56. Schneider, B; Biondi, R; Sarfati, R; Agou, F; Guerreiro, C; Deville-Bonne, D; Veron, M
    The mechanism of phosphorylation of anti-HIV D4T by nucleoside diphosphatekinase
    MOLECULAR PHARMACOLOGY
    
    B. Schneider et al., "The mechanism of phosphorylation of anti-HIV D4T by nucleoside diphosphatekinase", MOLEC PHARM, 57(5), 2000, pp. 948-953
57. van Rossum, AMC; Niesters, HGM; Geelen, SPM; Scherpbier, HJ; Hartwig, NG; Weemaes, CMR; Veerman, AJP; Suur, MH; de Graeff-Meeder, ER; Slicker, WAT; Hop, WCJ; Osterhaus, ADME; Burger, DM; de Groot, R
    Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: A multicenter study in The Netherlands
    JOURNAL OF PEDIATRICS
    
    A.M.C. van Rossum et al., "Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: A multicenter study in The Netherlands", J PEDIAT, 136(6), 2000, pp. 780-788
58. Zylberberg, H; Benhamou, Y; Lagneaux, JL; Landau, A; Chaix, ML; Fontaine, H; Bochet, M; Poynard, T; Katlama, C; Pialoux, G; Brechot, C; Pol, S
    Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIVcoinfected subjects: an early report
    GUT
    
    H. Zylberberg et al., "Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIVcoinfected subjects: an early report", GUT, 47(5), 2000, pp. 694-697
59. Van, PN
    Current situation of nucleosidic reverse transcriptase inhibitors
    ANNALES DE MEDECINE INTERNE
    
    P.N. Van, "Current situation of nucleosidic reverse transcriptase inhibitors", ANN MED IN, 151(4), 2000, pp. 255-259
60. Frippiat, F; Derue, G; Heller, F; Honore, P; Moreau, M; Vandercam, B
    Acute pancreatitis associated with severe lactic acidosis in human immunodeficiency virus-infected patients receiving triple therapy
    JAC. Journal of antimicrobial chemotherapy
    
    F. Frippiat et al., "Acute pancreatitis associated with severe lactic acidosis in human immunodeficiency virus-infected patients receiving triple therapy", J ANTIMICRO, 45(3), 2000, pp. 411-412
61. Seminari, E; Maggiolo, F; Villani, P; Suter, F; Pan, A; Regazzi, MB; Tinelli, C; Maserati, R
    Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitors
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    E. Seminari et al., "Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitors", J ACQ IMM D, 22(5), 1999, pp. 453-460
62. Pollard, RB; Peterson, D; Hardy, D; Pottage, J; Murphy, RL; Gathe, J; Beall, G; Rutkievicz, V; Reynolds, L; Cross, AP; Dunkle, LM
    Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm(3)
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    
    R.B. Pollard et al., "Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm(3)", J ACQ IMM D, 22(1), 1999, pp. 39-48
63. McNicholl, IR; Palmer, SM; Ziska, DS; Cleary, JD
    Antiinfectives update: Focus on treatment and prevention of viral and associated infections
    ANNALS OF PHARMACOTHERAPY
    
    I.R. McNicholl et al., "Antiinfectives update: Focus on treatment and prevention of viral and associated infections", ANN PHARMAC, 33(5), 1999, pp. 607-614
64. Monpoux, F; Bongain, A; Berard, E; Gillet, JY
    Antiretroviral therapy and prophylaxis of maternal fetal transmission of HIV-1. Current and future strategies.
    ARCHIVES DE PEDIATRIE
    
    F. Monpoux et al., "Antiretroviral therapy and prophylaxis of maternal fetal transmission of HIV-1. Current and future strategies.", ARCH PED, 6(5), 1999, pp. 556-565
65. Shafer, RW; Vuitton, DA
    Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1
    BIOMEDICINE & PHARMACOTHERAPY
    
    R.W. Shafer e D.A. Vuitton, "Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1", BIOMED PHAR, 53(2), 1999, pp. 73-86
66. von Giesen, HJ; Hefter, H; Jablonowski, H; Arendt, G
    Stavudine and the peripheral nerve in HIV-1 infected patients
    JOURNAL OF NEUROLOGY
    
    H.J. von Giesen et al., "Stavudine and the peripheral nerve in HIV-1 infected patients", J NEUROL, 246(3), 1999, pp. 211-217
67. Kuritzkes, DR; Marschner, I; Johnson, VA; Bassett, R; Eron, JJ; Fischl, MA; Murphy, RL; Fife, K; Maenza, J; Rosandich, ME; Bell, D; Wood, K; Sommadossi, JP; Pettinelli, C
    Lamivudine in combination with zidovudine stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial
    AIDS
    
    D.R. Kuritzkes et al., "Lamivudine in combination with zidovudine stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial", AIDS, 13(6), 1999, pp. 685-694
68. Gallant, JE; Chaisson, RE; Keruly, JC; Moore, RD
    Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patients
    AIDS
    
    J.E. Gallant et al., "Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patients", AIDS, 13(2), 1999, pp. 225-229
69. Saint-Marc, T; Partisani, M; Poizot-Martin, I; Bruno, F; Rouviere, O; Lang, JM; Gastaut, JA; Touraine, JL
    A syndrome of peripheral fat wasting (lipodystrophy) in patients receivinglong-term nucleoside analogue therapy
    AIDS
    
    T. Saint-Marc et al., "A syndrome of peripheral fat wasting (lipodystrophy) in patients receivinglong-term nucleoside analogue therapy", AIDS, 13(13), 1999, pp. 1659-1667
70. Pellegrin, I; Izopet, J; Reynes, J; Denayrolles, M; Montes, B; Pellegrin, JL; Massip, P; Puel, J; Fleury, H; Segondy, M
    Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plusdidanosine combination therapy
    AIDS
    
    I. Pellegrin et al., "Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plusdidanosine combination therapy", AIDS, 13(13), 1999, pp. 1705-1709
71. Mobley, JE; Pollard, RB; Schrader, S; Adler, MH; Kelleher, T; McLaren, C
    Virological and immunological responses to once-daily dosing of didanosinein combination with stavudine
    AIDS
    
    J.E. Mobley et al., "Virological and immunological responses to once-daily dosing of didanosinein combination with stavudine", AIDS, 13(11), 1999, pp. F87-F93
72. de Jong, JJ; Goudsmit, J; Lukashov, VV; Hillebrand, ME; Baan, E; Huismans, R; Danner, SA; ten Veen, JH; de Wolf, F; Jurriaans, S
    Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs
    AIDS
    
    J.J. de Jong et al., "Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs", AIDS, 13(1), 1999, pp. 75-80
73. Elion, R; Kaul, S; Knupp, C; Adler, M; Cross, AP; Dunkle, LM; Kelleher, T
    The safety profile and antiviral activity of the combination of stavudine,didanosine, and nelfinavir in patients with HIV infection
    CLINICAL THERAPEUTICS
    
    R. Elion et al., "The safety profile and antiviral activity of the combination of stavudine,didanosine, and nelfinavir in patients with HIV infection", CLIN THER, 21(11), 1999, pp. 1853-1863
74. Izopet, J; Bicart-See, A; Pasquier, C; Sandres, K; Bonnet, E; Marchou, B; Puel, J; Massip, P
    Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine
    JOURNAL OF MEDICAL VIROLOGY
    
    J. Izopet et al., "Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine", J MED VIROL, 59(4), 1999, pp. 507-511
75. Kline, MW; Van Dyke, RB; Lindsey, JC; Gwynne, M; Culnane, M; Diaz, C; Yogev, R; McKinney, RE; Abrams, EJ; Mofenson, LM
    Combination therapy with stavudine (d47) plus didanosine (ddI) in childrenwith human immunodeficiency virus infection
    PEDIATRICS
    
    M.W. Kline et al., "Combination therapy with stavudine (d47) plus didanosine (ddI) in childrenwith human immunodeficiency virus infection", PEDIATRICS, 103(5), 1999, pp. E621-E626
76. Hurst, M; Noble, S
    Stavudine - An update of its use in the treatment of HIV infection
    DRUGS
    
    M. Hurst e S. Noble, "Stavudine - An update of its use in the treatment of HIV infection", DRUGS, 58(5), 1999, pp. 919-949
77. Tuntland, T; Odinecs, A; Pereira, CM; Nosbisch, C; Unadkat, JD
    In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    
    T. Tuntland et al., "In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus", AM J OBST G, 180(1), 1999, pp. 198-206
78. REDDY JP; REID JG; RENNER DA; QUINLAN SL; WEAVER DG; CHEN BC; STARK DR; GAO Q
    INDEPENDENT SYNTHESIS AND FATE STUDIES OF IMPURITIES IN-PROCESS INTERMEDIATES OF THE ANTI-AIDS DRUG D4T
    Organic process research & development
    
    J.P. Reddy et al., "INDEPENDENT SYNTHESIS AND FATE STUDIES OF IMPURITIES IN-PROCESS INTERMEDIATES OF THE ANTI-AIDS DRUG D4T", Organic process research & development, 2(3), 1998, pp. 203-207
79. HAWORTH SJ; CHRISTOFALO B; ANDERSON RD; DUNKLE LM
    A SINGLE-DOSE STUDY TO ASSESS THE PENETRATION OF STAVUDINE INTO HUMANCEREBROSPINAL-FLUID IN ADULTS
    Journal of acquired immune deficiency syndromes and human retrovirology
    
    S.J. Haworth et al., "A SINGLE-DOSE STUDY TO ASSESS THE PENETRATION OF STAVUDINE INTO HUMANCEREBROSPINAL-FLUID IN ADULTS", Journal of acquired immune deficiency syndromes and human retrovirology, 17(3), 1998, pp. 235-238
80. Bossi, P; Yvon, A; Mouroux, M; Huraux, JM; Agut, H; Calvez, V
    Mutations in the human immunodeficiency virus type 1 reverse transcriptasegene observed in stavudine and didanosine strains obtained by in vitro passages
    RESEARCH IN VIROLOGY
    
    P. Bossi et al., "Mutations in the human immunodeficiency virus type 1 reverse transcriptasegene observed in stavudine and didanosine strains obtained by in vitro passages", RES VIROL, 149(6), 1998, pp. 355-361
81. WINTERGERST U; HOFFMANN F; SOLDER B; NOTHEIS G; PETROPOULOU T; EBERLE J; GURTLER L; BELOHRADSKY BH
    COMPARISON OF 2 ANTIRETROVIRAL TRIPLE COMBINATIONS INCLUDING THE PROTEASE INHIBITOR INDINAVIR IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    The Pediatric infectious disease journal
    
    U. Wintergerst et al., "COMPARISON OF 2 ANTIRETROVIRAL TRIPLE COMBINATIONS INCLUDING THE PROTEASE INHIBITOR INDINAVIR IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS", The Pediatric infectious disease journal, 17(6), 1998, pp. 495-499
82. RUTSCHMANN OT; OPRAVIL M; ITEN A; MALINVERNI R; VERNAZZA PL; BUCHER HC; BERNASCONI E; SUDRE P; LEDUC D; YERLY S; PERRIN LH; HIRSCHEL B
    A PLACEBO-CONTROLLED TRIAL OF DIDANOSINE PLUS STAVUDINE, WITH AND WITHOUT HYDROXYUREA, FOR HIV-INFECTION
    AIDS
    
    O.T. Rutschmann et al., "A PLACEBO-CONTROLLED TRIAL OF DIDANOSINE PLUS STAVUDINE, WITH AND WITHOUT HYDROXYUREA, FOR HIV-INFECTION", AIDS, 12(8), 1998, pp. 71-77
83. HOGG RS; RHONE SA; YIP B; SHERLOCK C; CONWAY B; SCHECHTER MT; OSHAUGHNESSY MV; MONTANER JSG
    ANTIVIRAL EFFECT OF DOUBLE AND TRIPLE-DRUG COMBINATIONS AMONGST HIV-INFECTED ADULTS - LESSONS FROM THE IMPLEMENTATION OF VIRAL LOAD-DRIVEN ANTIRETROVIRAL THERAPY
    AIDS
    
    R.S. Hogg et al., "ANTIVIRAL EFFECT OF DOUBLE AND TRIPLE-DRUG COMBINATIONS AMONGST HIV-INFECTED ADULTS - LESSONS FROM THE IMPLEMENTATION OF VIRAL LOAD-DRIVEN ANTIRETROVIRAL THERAPY", AIDS, 12(3), 1998, pp. 279-284
84. RAFFI F; RELIQUET V; AUGER S; BESNIER JM; CHENNEBAULT JM; BILLAUD E; MICHELET C; PERRE P; LAFEUILLADE A; MAY T; BILLAUDEL S
    EFFICACY AND SAFETY OF STAVUDINE AND DIDANOSINE COMBINATION THERAPY IN ANTIRETROVIRAL-EXPERIENCED PATIENTS
    AIDS
    
    F. Raffi et al., "EFFICACY AND SAFETY OF STAVUDINE AND DIDANOSINE COMBINATION THERAPY IN ANTIRETROVIRAL-EXPERIENCED PATIENTS", AIDS, 12(15), 1998, pp. 1999-2005
85. HOETELMANS RMW; PROFIJT M; MEENHORST PL; MULDER JW; VANHEESWIJK RPG; BEIJNEN JH
    COTRIMOXAZOLE AND STAVUDINE INTERFERENCE IN A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS FOR DIDANOSINE IN HUMAN PLASMA
    Therapeutic drug monitoring
    
    R.M.W. Hoetelmans et al., "COTRIMOXAZOLE AND STAVUDINE INTERFERENCE IN A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS FOR DIDANOSINE IN HUMAN PLASMA", Therapeutic drug monitoring, 20(6), 1998, pp. 669-672
86. CHEN BC; QUINLAN SL; REID JG; SPECTOR RH
    A NEW THYMINE FREE SYNTHESIS OF THE ANTI-AIDS DRUG D4T VIA REGIO STEREO CONTROLLED BETA-ELIMINATION OF BROMOACETATES/
    Tetrahedron letters
    
    B.C. Chen et al., "A NEW THYMINE FREE SYNTHESIS OF THE ANTI-AIDS DRUG D4T VIA REGIO STEREO CONTROLLED BETA-ELIMINATION OF BROMOACETATES/", Tetrahedron letters, 39(8), 1998, pp. 729-732
87. MUELLER BU; NELSON RP; SLEASMAN J; ZUCKERMAN J; HEATHCHIOZZI M; STEINBERG SM; BALIS FM; BROUWERS P; HSU A; SAULIS R; SEI S; WOOD LV; ZEICHNER S; KATZ TTK; HIGHAM C; AKER D; EDGERLY M; JAROSINSKI P; SERCHUCK L; WHITCUP SM; PIZZUTI D; PIZZO PA
    A PHASE I II STUDY OF THE PROTEASE INHIBITOR RITONAVIR IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/
    Pediatrics
    
    B.U. Mueller et al., "A PHASE I II STUDY OF THE PROTEASE INHIBITOR RITONAVIR IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/", Pediatrics, 101(3), 1998, pp. 335-343
88. KLINE MW; VANDYKE RB; LINDSEY JC; GWYNNE M; CULNANE M; MCKINNEY RE; NICHOLS S; MITCHELL WG; YOGEV R; HUTCHEON N
    A RANDOMIZED COMPARATIVE TRIAL OF STAVUDINE (D4T) VERSUS ZIDOVUDINE (ZDV, AZT) IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    Pediatrics
    
    M.W. Kline et al., "A RANDOMIZED COMPARATIVE TRIAL OF STAVUDINE (D4T) VERSUS ZIDOVUDINE (ZDV, AZT) IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION", Pediatrics, 101(2), 1998, pp. 214-220
89. THOMAS SA; SEGAL MB
    THE TRANSPORT OF THE ANTI-HIV DRUG, 2',3'-DIDEHYDRO-3'DEOXYTHYMIDINE (D4T), ACROSS THE BLOOD-BRAIN AND BLOOD CEREBROSPINAL-FLUID BARRIERS
    British Journal of Pharmacology
    
    S.A. Thomas e M.B. Segal, "THE TRANSPORT OF THE ANTI-HIV DRUG, 2',3'-DIDEHYDRO-3'DEOXYTHYMIDINE (D4T), ACROSS THE BLOOD-BRAIN AND BLOOD CEREBROSPINAL-FLUID BARRIERS", British Journal of Pharmacology, 125(1), 1998, pp. 49-54
90. KATLAMA C; VALANTIN MA; MATHERON S; COUTELLIER A; CALVEZ V; DESCAMPS D; LONGUET C; BONMARCHAND M; TUBIANA R; DESA M; LANCAR R; AGUT H; BRUNVEZINET F; COSTAGLIOLA D
    EFFICACY AND TOLERABILITY OF STAVUDINE PLUS LAMIVUDINE IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH HIV-1 INFECTION
    Annals of internal medicine
    
    C. Katlama et al., "EFFICACY AND TOLERABILITY OF STAVUDINE PLUS LAMIVUDINE IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH HIV-1 INFECTION", Annals of internal medicine, 129(7), 1998, pp. 525
91. MELTON ST; KIRKWOOD CK; GHAEMI SN
    PHARMACOTHERAPY OF HIV DEMENTIA
    The Annals of pharmacotherapy
    
    S.T. Melton et al., "PHARMACOTHERAPY OF HIV DEMENTIA", The Annals of pharmacotherapy, 31(4), 1997, pp. 457-473
92. BRODY SR; AWEEKA FT
    PHARMACOKINETICS OF INTRACELLULAR ZIDOVUDINE AND ITS PHOSPHORYLATED ANABOLITES IN THE ABSENCE AND PRESENCE OF USING AN IN-VITRO HUMAN PERIPHERAL-BLOOD MONONUCLEAR CELL (PBMC) MODEL
    International journal of antimicrobial agents
    
    S.R. Brody e F.T. Aweeka, "PHARMACOKINETICS OF INTRACELLULAR ZIDOVUDINE AND ITS PHOSPHORYLATED ANABOLITES IN THE ABSENCE AND PRESENCE OF USING AN IN-VITRO HUMAN PERIPHERAL-BLOOD MONONUCLEAR CELL (PBMC) MODEL", International journal of antimicrobial agents, 9(2), 1997, pp. 131-135
93. YANG Z; BRUNDAGE RC; BARBHAIYA RH; SAWCHUK RJ
    MICRODIALYSIS STUDIES OF THE DISTRIBUTION OF STAVUDINE INTO THE CENTRAL-NERVOUS-SYSTEM IN THE FREELY-MOVING RAT
    Pharmaceutical research
    
    Z. Yang et al., "MICRODIALYSIS STUDIES OF THE DISTRIBUTION OF STAVUDINE INTO THE CENTRAL-NERVOUS-SYSTEM IN THE FREELY-MOVING RAT", Pharmaceutical research, 14(7), 1997, pp. 865-872
94. FAMULARO G; MORETTI S; MARCELLINI S; TRINCHIERI V; TZANTZOGLOU S; SANTINI G; LONGO A; DESIMONE C
    ACETYL-CARNITINE DEFICIENCY IN AIDS PATIENTS WITH NEUROTOXICITY ON TREATMENT WITH ANTIRETROVIRAL NUCLEOSIDE ANALOGS
    AIDS
    
    G. Famularo et al., "ACETYL-CARNITINE DEFICIENCY IN AIDS PATIENTS WITH NEUROTOXICITY ON TREATMENT WITH ANTIRETROVIRAL NUCLEOSIDE ANALOGS", AIDS, 11(2), 1997, pp. 185-190
95. SPRUANCE SL; PAVIA AT; MELLORS JW; MURPHY R; GATHE J; STOOL E; JEMSEK JG; DELLAMONICA P; CROSS A; DUNKLE L
    CLINICAL EFFICACY OF MONOTHERAPY WITH STAVUDINE COMPARED WITH ZIDOVUDINE IN HIV-INFECTED, ZIDOVUDINE-EXPERIENCED PATIENTS - A RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL
    Annals of internal medicine
    
    S.L. Spruance et al., "CLINICAL EFFICACY OF MONOTHERAPY WITH STAVUDINE COMPARED WITH ZIDOVUDINE IN HIV-INFECTED, ZIDOVUDINE-EXPERIENCED PATIENTS - A RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL", Annals of internal medicine, 126(5), 1997, pp. 355
96. TUNTLAND T; NOSBISCH C; UNADKAT JD
    EFFECT OF PREGNANCY, MODE OF ADMINISTRATION AND NEONATAL AGE ON THE PHARMACOKINETICS OF ZALCITABINE (2',3'-DIDEOXYCYTIDINE) IN THE PIGTAILED MACAQUE (MACACA-NEMESTRINA)
    JAC. Journal of antimicrobial chemotherapy
    
    T. Tuntland et al., "EFFECT OF PREGNANCY, MODE OF ADMINISTRATION AND NEONATAL AGE ON THE PHARMACOKINETICS OF ZALCITABINE (2',3'-DIDEOXYCYTIDINE) IN THE PIGTAILED MACAQUE (MACACA-NEMESTRINA)", JAC. Journal of antimicrobial chemotherapy, 40(5), 1997, pp. 687-693
97. DOBKIN JF
    3RD RETROVIRUS CONFERENCE - MAGIC
    Complications in surgery
    
    J.F. Dobkin, "3RD RETROVIRUS CONFERENCE - MAGIC", Complications in surgery, 15(1), 1996, pp. 117-117
98. KAUL S; STOUFFER B; MUMMANENI V; TURABI N; MANTHA S; JAYATILAK P; BARBHAIYA R
    SPECIFIC RADIOIMMUNOASSAYS FOR THE MEASUREMENT OF STAVUDINE IN HUMAN PLASMA AND URINE
    Journal of pharmaceutical and biomedical analysis
    
    S. Kaul et al., "SPECIFIC RADIOIMMUNOASSAYS FOR THE MEASUREMENT OF STAVUDINE IN HUMAN PLASMA AND URINE", Journal of pharmaceutical and biomedical analysis, 15(2), 1996, pp. 165-174
99. DISCORDIA RP
    SYNTHESIS OF 1'-[C-14]-STAVUDINE(R) (D4T)
    Journal of labelled compounds & radiopharmaceuticals
    
    R.P. Discordia, "SYNTHESIS OF 1'-[C-14]-STAVUDINE(R) (D4T)", Journal of labelled compounds & radiopharmaceuticals, 38(7), 1996, pp. 613-623
100. STYRT BA; PIAZZAHEPP TD; CHIKAMI GK
     CLINICAL TOXICITY OF ANTIRETROVIRAL NUCLEOSIDE ANALOGS
     Antiviral research
     
     B.A. Styrt et al., "CLINICAL TOXICITY OF ANTIRETROVIRAL NUCLEOSIDE ANALOGS", Antiviral research, 31(3), 1996, pp. 121-135